New therapy could help stop age-related blindness

Age-related macular degeneration is the leading cause of legal blindness in New Zealand, but a now therapy being developed in Australia may offer sufferers some hope.

It will affect one in seven people over the age of 60 and has few warning signs. Joshua Chu-Tan is a researcher at Australian National University and has taken microRNA and injected it straight into the eye.

He joins Lynn to explain what his research discovered.

New therapy could help stop age-related blindness
0:00 / 15:12